Haemonetics Corp HAE

US Health Care

$85.54 ▲ +0.85% (+$0.72)

📈 Near 52W High 📅 Earnings This Week

Open $84.26

Prev Close $84.82

Day Range $82.75 – $85.61

52W Range $47.32 – $87.32

Market Cap $3.89B

P/E (TTM) 39.24

Beta 0.53

EPS (TTM) $2.03

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	1979-10-17
Shares Out.	45,450,000
Website	haemonetics.com ↗
Phone	17818487100
Employees	3,009
Revenue	$346.4M
Gross Profit	$198.2M
Net Income	-$20.1M
Free Cash Flow	$208.6M
Total Assets	$2.40B
Total Liabilities	$1.60B
Equity	$796.3M

About Haemonetics Corp

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Haemonetics Corp is a publicly traded company under the ticker symbol HAE on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.